New cancer drug AWT020 enters first human trial
Disease control
Recruiting now
This early-phase trial is testing a new biologic drug called AWT020 in 60 adults with advanced solid tumors or lymphoma that have worsened after standard treatments. The main goals are to check the drug's safety at different doses and to see how the body processes it. Participant…
Phase: PHASE1 • Sponsor: Anwita Biosciences • Aim: Disease control
Last updated Jun 26, 2026 12:47 UTC